FDAFDA · Food and drugs·Recall number D-1099-2018
Contrave (naltrexone HCl and bupropion HCl) Extended-Release Tablets, 8 mg/90 mg, 120-count bottle, Rx only, Distributed by Orexigen therapeutics, Inc., La Jolla, CA 92037, NDC 51267-890-99.
Published August 22, 2018 · Recall initiated: August 9, 2018
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Defective Container: Customer complaints of punctures in the bottle.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- CONTRAVE
- Manufacturer
- Orexigen Therapeutics, Inc.
- Distributor
- Nationwide in the USA
- UPC
- 0351267890997
- Lot
- Lot #: ZCXM, Exp 01NOV2020; ZCXN, Exp 02NOV2020; ZCXP, Exp 09NOV2020; ZCXS, 10NOV2020; ZCXT, Exp 13NOV2020; and ZCXV, Exp 17NOV2020
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.